LAPATINIB POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

申请号：

EP10810654.3

公开号：

EP2467140B1

申请日:

2010.08.20

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Methods are provided of treating a human for cancer comprising administering at least one dose of lapatinib, or a pharmaceutically acceptable salt or composition thereof, to a patient, wherein said patient does not have one or more allelic polymorphisms selected from the group of: HLA-DQA1*0201, HLA-DQB1*0202, and HLA-DRB1*0701. Patients may also be free of genotypes in TNXB； rs12153855 and/or rs17207923.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/